Abstract
Background:
Vitamin D deficiency is a widely recognized public health problem. Efficacy of a recently developed micellized form of vitamin D3 has not been studied. Hence, we undertook this study to compare its efficacy with the conventionally used fat-soluble vitamin D3.
Methods:
In this open-labeled nonrandomized pilot study, we recruited 180 healthy children, aged 13–14 years in two groups and supplemented Group A (60 children) with 60,000 IU of fat-soluble vitamin D3/month with milk and Group B (120 children) with 60,000 IU/month of water miscible vitamin D3 under supervision for 6 months. Serum 25(OD)D, parathyroid hormone (PTH), calcium, phosphate, and alkaline phosphatase (ALP) levels were evaluated before and after supplementation in 156 children (54 in Group A and 102 in Group B) who completed the study.
Results:
We observed a significantly greater increase in the serum 25(OH)D levels in group B as compared to group A (31.8±9.1 ng/mL vs. 23.7±10.4 ng/mL; p<0.001). All children in group B achieved adequate levels of serum 25(OH)D (>20 ng/mL) as against 83.3% children in group A. Serum PTH and ALP levels declined considerably in both the groups following supplementation.
Conclusions:
Vitamin D supplementation significantly increased the serum 25(OH)D levels in both groups. Miscible form of vitamin D3 appears to be better in achieving higher levels of serum 25(OH)D than that observed with a similar dose of fat-soluble vitamin D3. Further studies with different dose regimens are required to establish its efficacy over the conventionally used fat-soluble vitamin D3.
Acknowledgments
We gratefully acknowledge the school management, parents, and children for participating in the study. We also thank Ms Angel K. Thankachen for the technical help in performing the biochemical assays.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: Society for Endocrine Health of Elderly, Adolescents and Children (SEHEAC).
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–81.10.1056/NEJMra070553Search in Google Scholar PubMed
2. Wahl DA, Cooper C, Ebeling PR, Eggersdorfer M, Hilger J, et al. Global representation of vitamin D status in healthy populations. Arch Osteoporos 2012;7:155–72.10.1007/s11657-012-0093-0Search in Google Scholar PubMed
3. Charzewska J, Chlebna-Sokół D, Chybicka A, Czech-Kowalska J, Dobrzańska A, et al. Recommendations of prophylaxis of vitamin D deficiency in Poland (2009). Med Wieku Rozwoj 2010;14:218–23.Search in Google Scholar
4. Takács I, Benkő I, Toldy E, Wikonkál N, Szekeres L, et al. Hungarian consensus regarding the role of vitamin D in the prevention and treatment of diseases. Orv Hetil 2012;153:5–26.10.1556/OH.2012.29410Search in Google Scholar PubMed
5. German Nutrition Society. New reference values for vitamin D. Ann Nutr Metab 2012;60:241–6.10.1159/000337547Search in Google Scholar PubMed
6. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press, 2011.Search in Google Scholar
7. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–30.10.1210/jc.2011-0385Search in Google Scholar PubMed
8. Borel P, Caillaud D, Cano NJ. Vitamin D bioavailability: state of the art. Crit Rev Food Sci Nutr 2015;55:1193–205.10.1080/10408398.2012.688897Search in Google Scholar PubMed
9. Micellized Vitamin D3 Liquid: Micellization technology makes Vitamin D More Bioavailable. Prothera Inc. Update Fall, 2010.Search in Google Scholar
10. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001;22:477–501.10.1210/edrv.22.4.0437Search in Google Scholar PubMed
11. Rath B, Aggarwal MK, Mishra TK, Talukdar B, Murthy NS, et al. Urinary calcium creatinine ratio and hypercalciuria. Indian Pediatr 1994;31:311–6.Search in Google Scholar
12. Marwaha RK, Tandon N, Reddy DR, Aggarwal R, Singh R, et al. Vitamin D and bone mineral density status of healthy schoolchildren in northern India. Am J Clin Nutr 2005;82:477–82.10.1093/ajcn/82.2.477Search in Google Scholar
13. Puri S, Marwaha RK, Agarwal N, Tandon N, Agarwal R, et al. Vitamin D status of apparently healthy schoolgirls from two different socioeconomic strata in Delhi: relation to nutrition and lifestyle. Br J Nutr 2008;99:876–82.10.1017/S0007114507831758Search in Google Scholar PubMed
14. Marwaha RK, Tandon N, Agarwal N, Puri S, Agarwal R, et al. Impact of two regimens of vitamin D supplementation on calcium-vitamin D-PTH axis of schoolgirls of Delhi. Indian Pediatr 2010;47:761–9.10.1007/s13312-010-0116-0Search in Google Scholar PubMed
15. Kuchay MS, Jevalikar GS, Mithal A, Mishra SK, Dang N. Efficacy and safety of a single monthly dose of cholecalciferol in healthy school children. J Pediatr Endocrinol Metab 2016;29:413–6.10.1515/jpem-2015-0187Search in Google Scholar PubMed
16. Biesalski HK. Bioavailability of vitamin A. Eur J Clin Nutr 1997;51:S71–5.Search in Google Scholar
17. Jacquemin E, Hermeziu B, Kibleur Y, Friteau I, Mathieu D, et al. Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis. J Clin Pharm Ther 2009;34:515–22.10.1111/j.1365-2710.2009.01027.xSearch in Google Scholar PubMed
18. Garg MK, Tandon N, Marwaha RK, Menon AS, Mahalle N. The relationship between serum 25-hydroxy vitamin D, parathormone and bone mineral density in Indian population. Clin Endocrinol (Oxf). 2014;80:41–6.10.1111/cen.12248Search in Google Scholar PubMed
19. Viljakainen HT, Natri AM, Karkkainen M, Huttunen MM, Palssa A, et al. A positive dose-response effect of vitamin D supplementation on site-specific bone mineral augmentation in adolescent girls: a double-blinded randomized placebo-controlled 1 year intervention. J Bone Miner Res 2006;21:836–44.10.1359/jbmr.060302Search in Google Scholar PubMed
20. Charles ND. The many causes of subclinical hyperthyroidism. Thyroid 1996;6:391–6.10.1089/thy.1996.6.391Search in Google Scholar PubMed
21. El-Hajj Fuleihan G, Nabulsi M, Tamim H, Maalouf J, Salamoun M, et al. Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomised controlled trial. J Clin Endocrinol Metab 2006;91:405–12.10.1210/jc.2005-1436Search in Google Scholar PubMed
22. Rajakumar K, Fernsttrom JD, Janosky JE, Greenspan SL. Vitamin D insufficiency in preadolescent African-American children. Clin Pediatr 2005;44:683–92.10.1177/000992280504400806Search in Google Scholar PubMed
23. Maalouf J, Nabulsi M, Vieth R, Kimball S, El-Rassi R, et al. Short term and long term safety of weekly high dose vitamin D3 supplementation in school children. J Clin Endocrin Metab 2008;93:2693–701.10.1210/jc.2007-2530Search in Google Scholar PubMed PubMed Central
©2016 Walter de Gruyter GmbH, Berlin/Boston
